| scholarly article | Q13442814 |
| P356 | DOI | 10.1096/FASEBJ.13.3.477 |
| P698 | PubMed publication ID | 10064614 |
| P50 | author | Stephen R Russell | Q44883012 |
| P2093 | author name string | D H Anderson | |
| G S Hageman | |||
| R F Mullins | |||
| L V Johnson | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drusen | Q1140528 |
| P304 | page(s) | 477-484 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells | |
| P478 | volume | 13 |
| Q24523983 | A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration |
| Q34809064 | A role for local inflammation in the formation of drusen in the aging eye. |
| Q37391097 | Accumulation of extracellular RGR-d in Bruch's membrane and close association with drusen at intercapillary regions |
| Q33874401 | Aceruloplasminemia: retinal histopathologic manifestations and iron-mediated melanosome degradation |
| Q28365776 | Advanced glycation: an important pathological event in diabetic and age related ocular disease |
| Q35126780 | Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies |
| Q82698020 | Age-related macular degeneration |
| Q33263472 | Age-related macular degeneration--emerging pathogenetic and therapeutic concepts |
| Q33894963 | Age-related retinopathy in NRF2-deficient mice. |
| Q35056603 | Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins |
| Q35105102 | Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. |
| Q33634096 | Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration |
| Q42434913 | Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits |
| Q35221016 | Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration |
| Q35589100 | Basement membranes and artificial substrates in cell transplantation |
| Q37028109 | C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration |
| Q37110107 | Ca2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease. |
| Q58396815 | Can laser photocoagulation of eyes with high-risk drusen prevent vision loss from age-related macular degeneration? |
| Q21260371 | Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina |
| Q36477011 | Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration |
| Q37351470 | Common coding variants in the HLA-DQB1 region confer susceptibility to age-related macular degeneration |
| Q33909890 | Comparison of drusen and modifying genes in autosomal dominant radial drusen and age-related macular degeneration |
| Q46022690 | Complement factor H in AMD: Bridging genetic associations and pathobiology. |
| Q28542387 | Complement factor H, vitronectin, and opticin are tyrosine-sulfated proteins of the retinal pigment epithelium |
| Q33382097 | Complement factor H: using atomic resolution structure to illuminate disease mechanisms |
| Q28534455 | DJ-1-dependent regulation of oxidative stress in the retinal pigment epithelium (RPE) |
| Q35083573 | Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. |
| Q37733102 | Dietary hyperglycemia, glycemic index and metabolic retinal diseases |
| Q48256943 | Diseases of complement dysregulation-an overview |
| Q102152298 | Drusen and pachydrusen: the definition, pathogenesis, and clinical significance |
| Q41832044 | Drusen characterization with multimodal imaging |
| Q34331346 | Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers |
| Q34378842 | Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. |
| Q28590177 | Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration |
| Q37395303 | Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging |
| Q34600004 | Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream. |
| Q42012939 | Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration |
| Q41105949 | Exploring the cross talk between ER stress and inflammation in age-related macular degeneration. |
| Q21202837 | Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin |
| Q36860952 | Geographic atrophy: a histopathological assessment |
| Q51032252 | Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits. |
| Q44857437 | HYPERSPECTRAL AUTOFLUORESCENCE IMAGING OF DRUSEN AND RETINAL PIGMENT EPITHELIUM IN DONOR EYES WITH AGE-RELATED MACULAR DEGENERATION. |
| Q35062847 | Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye |
| Q36739706 | Immunopathological aspects of age-related macular degeneration |
| Q35768692 | Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid |
| Q26768520 | Inflammation and its role in age-related macular degeneration |
| Q35755942 | Inflammatory Mechanisms of Age-related Macular Degeneration |
| Q90010378 | Inflammatory Ocular Diseases and Sphingolipid Signaling |
| Q39935713 | Innate immune network in the retina activated by optic nerve crush |
| Q60916938 | Interplay between Autophagy and the Ubiquitin-Proteasome System and Its Role in the Pathogenesis of Age-Related Macular Degeneration |
| Q35862230 | Keypathophysiologic pathways in age-related macular disease |
| Q30671842 | Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation |
| Q42186047 | Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration |
| Q73465771 | Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration |
| Q35671535 | MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits |
| Q38064846 | Mechanism of inflammation in age-related macular degeneration |
| Q61812759 | Metabolomics and Age-Related Macular Degeneration |
| Q37273740 | Molecular pathology of age-related macular degeneration |
| Q35610903 | Novel role for alphavbeta5-integrin in retinal adhesion and its diurnal peak |
| Q37361026 | PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration. |
| Q50188502 | Performance characteristics of multicolor versus blue light and infrared imaging in the identification of reticular pseudodrusen |
| Q36894556 | Progress in defining the molecular biology of age related macular degeneration |
| Q36746897 | Quantification of fluorescein-stained drusen associated with age-related macular degeneration |
| Q35013968 | Reticular drusen over time with SD-OCT |
| Q35688325 | Retinal phagocytes in age-related macular degeneration |
| Q43162540 | Role of Factor H and Related Proteins in Regulating Complement Activation in the Macula, and Relevance to Age-Related Macular Degeneration. |
| Q38394797 | Role of tyrosine-sulfated proteins in retinal structure and function |
| Q38688358 | Roles of exosomes in the normal and diseased eye. |
| Q33735695 | Soluble and mature amyloid fibrils in drusen deposits |
| Q41042963 | Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration |
| Q37587896 | Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating |
| Q43671971 | Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. |
| Q38543289 | Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration. |
| Q37034708 | Sub-retinal drusenoid deposits in human retina: organization and composition |
| Q36666116 | Targeting of exon VI-skipping human RGR-opsin to the plasma membrane of pigment epithelium and co-localization with terminal complement complex C5b-9 |
| Q34154466 | The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration |
| Q44796280 | The effect of zinc on the apoptosis of cultured human retinal pigment epithelial cells |
| Q37678798 | The molecular genetic basis of age-related macular degeneration: an overview |
| Q37644606 | The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited |
| Q26997523 | The proteomics of drusen |
| Q36405906 | The role of inflammation in the pathogenesis of age-related macular degeneration |
| Q24623107 | Therapeutic targets in age-related macular disease |
| Q35175185 | Vitronectin expression in the airways of subjects with asthma and chronic obstructive pulmonary disease |
Search more.